Amarin Corp PLC (AMRN)
0.551
+0.03
(+4.97%)
USD |
NASDAQ |
Nov 22, 14:33
Amarin Total Assets (Quarterly): 750.62M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 750.62M |
June 30, 2024 | 799.86M |
March 31, 2024 | 790.01M |
December 31, 2023 | 831.68M |
September 30, 2023 | 839.03M |
June 30, 2023 | 860.02M |
March 31, 2023 | 860.19M |
December 31, 2022 | 886.18M |
September 30, 2022 | 908.30M |
June 30, 2022 | 973.24M |
March 31, 2022 | 973.71M |
December 31, 2021 | 1.068B |
September 30, 2021 | 1.036B |
June 30, 2021 | 1.045B |
March 31, 2021 | 990.25M |
December 31, 2020 | 966.02M |
September 30, 2020 | 960.20M |
June 30, 2020 | 914.87M |
March 31, 2020 | 925.67M |
December 31, 2019 | 882.21M |
September 30, 2019 | 866.94M |
June 30, 2019 | 389.92M |
March 31, 2019 | 372.24M |
December 31, 2018 | 385.71M |
September 30, 2018 | 210.29M |
Date | Value |
---|---|
June 30, 2018 | 204.13M |
March 31, 2018 | 215.71M |
December 31, 2017 | 161.60M |
September 30, 2017 | 166.61M |
June 30, 2017 | 170.18M |
March 31, 2017 | 175.20M |
December 31, 2016 | 167.00M |
September 30, 2016 | 193.90M |
June 30, 2016 | 147.64M |
March 31, 2016 | 152.71M |
December 31, 2015 | 173.23M |
September 30, 2015 | 182.42M |
June 30, 2015 | 195.16M |
March 31, 2015 | 215.34M |
December 31, 2014 | 171.11M |
September 30, 2014 | 185.37M |
June 30, 2014 | 205.84M |
March 31, 2014 | 220.21M |
December 31, 2013 | 252.48M |
September 30, 2013 | 293.85M |
June 30, 2013 | 214.67M |
March 31, 2013 | 271.33M |
December 31, 2012 | 310.86M |
September 30, 2012 | 255.00M |
June 30, 2012 | 271.18M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
750.62M
Minimum
Sep 2024
1.068B
Maximum
Dec 2021
913.05M
Average
911.59M
Median
Total Assets (Quarterly) Benchmarks
Trinity Biotech PLC | 97.45M |
Adaptimmune Therapeutics PLC | 317.44M |
Akari Therapeutics PLC | 2.734M |
NuCana PLC | 25.38M |
TC BioPharm (Holdings) PLC | 9.171M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 219.24M |
Shareholders Equity (Quarterly) | 531.38M |
Current Ratio | 3.226 |